Shenzhen Hepalink Pharmaceutical Group Co Ltd (SHEZF) Price
SHEZF Stock Price Chart
SHEZF Financial
Shenzhen Hepalink Pharmaceutical Group Co Ltd
$0
0%
$0
Income
Balance sheet
Cash flow
Annual
Quarterly
SHEZF Income
Financials in millions USD. Fiscal year is February - January.
| Breakdown | TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 |
|---|---|---|---|---|---|---|
| Revenue | 5,260 | 5,280 | 5,445 | 7,159 | 6,365 | 5,332 |
| Revenue Growth (YoY) | -6% | -3% | -24% | 12% | 19% | 15% |
| Cost of Revenue | 3,655 | 3,532 | 4,501 | 4,863 | 4,367 | 3,300 |
| Gross Profit | 1,605 | 1,748 | 944 | 2,295 | 1,998 | 2,031 |
| Selling, General & Admin | 855 | 781 | 930 | 972 | 878 | 767 |
| Research & Development | 233 | 203 | 173 | 244 | 216 | 154 |
| Operating Expenses | 1,297 | 1,099 | 1,232 | 1,292 | 1,186 | 996 |
| Other Non Operating Income (Expenses) | 0 | -14 | -66 | 1 | -4 | -1 |
| Pretax Income | 442 | 726 | -928 | 829 | 222 | 1,327 |
| Income Tax Expense | 58 | 101 | -126 | 114 | -11 | 306 |
| Net Income | 404 | 646 | -783 | 727 | 240 | 1,024 |
| Net Income Growth | -267% | -183% | -208% | 202.99% | -77% | -3% |
| Shares Outstanding (Diluted) | 1,467.29 | 1,467.29 | 1,467.29 | 1,467.29 | 1,467.29 | 1,467.3 |
| Shares Change (YoY) | 0% | 0% | 0% | 0% | 0% | 18% |
| EPS (Diluted) | 0.27 | 0.44 | -0.53 | 0.49 | 0.16 | 0.7 |
| EPS Growth | -267% | -183% | -208% | 202% | -77% | -18% |
| Free Cash Flow | 1,751 | 1,991 | -46 | -979 | -200 | -175 |
| Free Cash Flow Per Share | 1.19 | 1.35 | -0.03 | -0.66 | -0.13 | -0.11 |
| Gross Margin | 30.51% | 33.1% | 17.33% | 32.05% | 31.39% | 38.09% |
| Operating Margin | 5.85% | 12.27% | -5.28% | 14.01% | 12.74% | 19.41% |
| Profit Margin | 7.68% | 12.23% | -14.38% | 10.15% | 3.77% | 19.2% |
| Free Cash Flow Margin | 33.28% | 37.7% | -0.84% | -13.67% | -3.14% | -3.28% |
| EBITDA | -- | 744 | -188 | 1,095 | 911 | 1,136 |
| EBITDA Margin | -- | 14.09% | -3.45% | 15.29% | 14.31% | 21.3% |
| D&A For EBITDA | -- | 96 | 100 | 92 | 100 | 101 |
| EBIT | 308 | 648 | -288 | 1,003 | 811 | 1,035 |
| EBIT Margin | 5.85% | 12.27% | -5.28% | 14.01% | 12.74% | 19.41% |
| Effective Tax Rate | 13.12% | 13.91% | 13.57% | 13.75% | -4.95% | 23.05% |
Follow-Up Questions
¿Cuáles son los estados financieros clave de Shenzhen Hepalink Pharmaceutical Group Co Ltd?
¿Cuáles son los ratios financieros clave para SHEZF?
¿Cómo se desglosan los ingresos de Shenzhen Hepalink Pharmaceutical Group Co Ltd por segmento o geografía?
¿Es rentable Shenzhen Hepalink Pharmaceutical Group Co Ltd?
¿Tiene Shenzhen Hepalink Pharmaceutical Group Co Ltd alguna deuda?
¿Cuántas acciones en circulación tiene Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Features
Trading Strategies
Resources
© 2025 Edgen Powered by
Ask AI About SHEZF